File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Postradiation sarcoma after radiotherapy for nasopharyngeal carcinoma

TitlePostradiation sarcoma after radiotherapy for nasopharyngeal carcinoma
Authors
Issue Date2012
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.laryngoscope.com/
Citation
The Laryngoscope, 2012, v. 122 n. 12, p. 2695-2699 How to Cite?
AbstractOBJECTIVES/HYPOTHESIS: Postradiation sarcoma (PRS) is a notorious complication after radiotherapy (RT). The prognosis is poor, and the role of surgery is not well defined. The aim of our study was to review our experience in the management of PRS after RT for nasopharyngeal carcinoma (NPC). STUDY DESIGN: Case series. METHODS: Between 1998 and 2011, all patients treated for PRS after radiation for NPC were reviewed retrospectively. RESULTS: Twenty-five patients were included. The mean latency period for the development of PRS after previous RT was 12.4 years. The histologic subtypes included osteosarcoma (n = 8), rhabdomyosarcoma (n = 6), undifferentiated sarcoma (n = 6), malignant fibrous histiocytoma (n = 4), and leiomyosarcoma (n = 1). Twenty patients underwent surgery with curative intent, but 14 of them eventually had microscopic positive resection margins. Among them, all received postoperative adjuvant chemoradiation, and six of them had brachytherapy as well. However, 71.4% of them eventually developed local recurrence. The median survival was significantly better for those with clear margin resection than for those with positive margins (5.12 years vs. 1.44 years, P = .04). Surgery was effective in symptom palliation, including tumor pain, bleeding, and trismus. CONCLUSIONS: PRS remains a disease with poor prognosis. Surgical resection with clear margins achieves significantly better survival. Surgery is also effective in the palliation of pain, bleeding, and trismus in patients with advanced staged disease.
Persistent Identifierhttp://hdl.handle.net/10722/184743
ISSN
2023 Impact Factor: 2.2
2023 SCImago Journal Rankings: 1.128
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChan, JYW-
dc.contributor.authorWong, STS-
dc.contributor.authorLau, GISK-
dc.contributor.authorWei, WI-
dc.date.accessioned2013-07-15T10:07:10Z-
dc.date.available2013-07-15T10:07:10Z-
dc.date.issued2012-
dc.identifier.citationThe Laryngoscope, 2012, v. 122 n. 12, p. 2695-2699-
dc.identifier.issn0023-852X-
dc.identifier.urihttp://hdl.handle.net/10722/184743-
dc.description.abstractOBJECTIVES/HYPOTHESIS: Postradiation sarcoma (PRS) is a notorious complication after radiotherapy (RT). The prognosis is poor, and the role of surgery is not well defined. The aim of our study was to review our experience in the management of PRS after RT for nasopharyngeal carcinoma (NPC). STUDY DESIGN: Case series. METHODS: Between 1998 and 2011, all patients treated for PRS after radiation for NPC were reviewed retrospectively. RESULTS: Twenty-five patients were included. The mean latency period for the development of PRS after previous RT was 12.4 years. The histologic subtypes included osteosarcoma (n = 8), rhabdomyosarcoma (n = 6), undifferentiated sarcoma (n = 6), malignant fibrous histiocytoma (n = 4), and leiomyosarcoma (n = 1). Twenty patients underwent surgery with curative intent, but 14 of them eventually had microscopic positive resection margins. Among them, all received postoperative adjuvant chemoradiation, and six of them had brachytherapy as well. However, 71.4% of them eventually developed local recurrence. The median survival was significantly better for those with clear margin resection than for those with positive margins (5.12 years vs. 1.44 years, P = .04). Surgery was effective in symptom palliation, including tumor pain, bleeding, and trismus. CONCLUSIONS: PRS remains a disease with poor prognosis. Surgical resection with clear margins achieves significantly better survival. Surgery is also effective in the palliation of pain, bleeding, and trismus in patients with advanced staged disease.-
dc.languageeng-
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.laryngoscope.com/-
dc.relation.ispartofThe Laryngoscope-
dc.subject.meshEndoscopy-
dc.subject.meshHead and Neck Neoplasms - diagnosis - etiology - surgery-
dc.subject.meshNasopharyngeal Neoplasms - radiotherapy-
dc.subject.meshNeoplasms, Radiation-Induced - diagnosis - etiology - surgery-
dc.subject.meshSarcoma - diagnosis - etiology - surgery-
dc.titlePostradiation sarcoma after radiotherapy for nasopharyngeal carcinoma-
dc.typeArticle-
dc.identifier.emailChan, JYW: jywchan1@hku.hk-
dc.identifier.emailWong, STS: thiansze@graduate.hku.hk-
dc.identifier.emailWei, WI: hrmswwi@hku.hk-
dc.identifier.authorityChan, JYW=rp01314-
dc.identifier.authorityWong, STS=rp00478-
dc.identifier.authorityWei, WI=rp00323-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1002/lary.23282-
dc.identifier.pmid23070724-
dc.identifier.scopuseid_2-s2.0-84871310739-
dc.identifier.hkuros215931-
dc.identifier.volume122-
dc.identifier.issue12-
dc.identifier.spage2695-
dc.identifier.epage2699-
dc.identifier.isiWOS:000312540000016-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats